Orchid Pharmaceuticals - Orchid Chemicals,pharmaceutical,cephalosporin,bulk drug,formulations,nutraceutical,orchid pharmaceuticals,research & development,pharmaceutical company,alendronate sodium tablets,new drug discovery,cefixime tablets,nimesulide dispersible tablets,amoldipine tablets,new drug delivery systems,quality manufacturing facilities,amlodipine atenolol tablets,sildenafil citrate tablets,ISO 9002,ISO 14001,investors, annual report,careers pharmaceutical,careers research & development,novel drug delivery systems,cefpodoxime proxetil tablets,quality control pharmaceutical formulations,pharmaceutical research,contract manufacture,bulk drug contract manufacture,formulations contract manufacture,contract research,state-of -the art R&D,lisinopril tablets

Ranbaxy Laboratories Limited (Ranbaxy) and Orchid Chemicals & Pharmaceuticals Limited (Orchid) today announced that they have entered into a Business Alliance Agreement involving multiple geographies and therapies for both finished dosage formulations and active pharmaceutical ingredients. Additionally, this agreement would establish a framework for enhanced future co-operation between the two companies.

Speaking on the development, Mr Malvinder Mohan Singh, CEO & MD, Ranbaxy, said, “Orchid is a niche player in the global pharmaceutical industry with an impressive track record, particularly in sterile products. We are pleased to enter into this long term strategic alliance with Orchid. The agreement will be mutually beneficial and synergistic, allowing both organisations to leverage each other’s inherent strengths”.

Commenting on the alliance, Mr K. Raghavendra Rao, Managing Director, Orchid Chemicals & Pharmaceuticals Ltd. said, “We are happy to join hands with Ranbaxy, India's largest pharmaceutical company. Ranbaxy's global scale and market reach and Orchid's state-of-the-art development and manufacturing capabilities would expand the business of both companies. We believe that this will be a win-win arrangement for both companies”.

About Ranbaxy:

Ranbaxy Laboratories Limited, India's largest pharmaceutical company, is an integrated, research based, international pharmaceutical company producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. Ranbaxy’s continued focus on R&D has resulted in several approvals in developed markets and significant progress in New Drug Discovery Research. The Company’s foray into Novel Drug Delivery Systems has led to proprietary "platform technologies," resulting in a number of products under development. The Company is serving its customers in over 125 countries and has an expanding international portfolio of affiliates, joint ventures and alliances, ground operations in 49 countries and manufacturing operations in 11 countries.